drugset / Trial / NCT02283814
A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate
RandomizedParallel-groupOpen-labelTreatment
Summary
Single centre, open-label, multiple doses, one-sequence design study in two parallel groups of healthy volunteers
Timeline
- Start
- 2007-01
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 600 mg | — |
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | — |
| Subject | Topiramate | Small molecule | 100 mg | — |
| Subject | Topiramate | Small molecule | 200 mg | — |